
Here, we bring you our top five recent news articles, covering delays in the cannabis rescheduling hearings, DoorDash’s expansion into hemp-derived products, and more.
Here, we bring you our top five recent news articles, covering delays in the cannabis rescheduling hearings, DoorDash’s expansion into hemp-derived products, and more.
In response to the recent announcement that the hearing concerning cannabis rescheduling had been delayed, Americans for Safe Access held a webinar discussing the impacts medical cannabis.
Cannabis legalization and regulation was noted as an issue with longtime support of a majority of voters in the state.
The recently passed amendment deprioritized cannabis enforcement in Dallas, Texas.
Our sister publication, Nutritional Outlook, covered the current regulatory landscape for hemp as a supplement and how the 2024 Farm Bill could change things in the near future.
The ruling states that federal law does not block the ban on certain cannabinoid products in the state.
A ruling is expected this week regarding the lawsuit challenging the validity of signatures collected for two medical cannabis measures.
Panelists discussed the impacts of cannabis as a schedule 3 substance on research, legislation, patients, and more.
The bill regulates the sale and distribution of products containing synthetic THC, though some challenges remain to be resolved.
As discussions about the federal scheduling of cannabis continue, efforts by medical cannabis advocates are intensifying. One such advocate is Americans for Safe Access (ASA), a nonprofit organization founded by patients for patients. Since 2002, ASA has been championing the rights of medical cannabis patients and has recently launched new campaigns and strategies to refocus attention on patient needs. In this interview, Steph Sherer, founder and president of ASA, reflects on past successes in medical cannabis advocacy, shares her perspective on recent cannabis and hemp policymaking, and outlines the next steps for advancing a unified medical cannabis message on Capitol Hill—a message that could bring about the changes patients have long awaited.
The latest webinar in this series explored challenges and solutions in the current and future landscape of cannabis policies and regulation.
Voters in North Dakota will see recreational cannabis on the ballot this November.
California’s bill creating new restrictions on intoxicating hemp products has prompted responses citing negative impacts on patients and businesses.
An executive order from the governor pardoned a significant number of cannabis convictions, noting the efforts to rectify harms from past cannabis policies.
In the General Session of the Cannabis Science Conference, Scheril Murray Powell, Esq. and John Calloway Jr. discussed the many ways equity ties into science in the cannabis industry.
One step forward, two steps back: updates on cannabis legal movements in three different states.
A ballot initiative to expand medical cannabis access in Arkansas has been resubmitted.
The recent approval of a bill brings Washington one step closer to long-awaited at-home recreational cannabis cultivation.
The Attorney General recently drafted a bill to legalize recreational cannabis in the state and also provided the office’s position on the issue.
A recently proposed bipartisan bill would affect criminal charges surrounding cannabis possession in the Badger State.
Recreational cannabis is legal in some capacities, but Ohioans cannot yet buy it.
A recent vote will place the bill before the president for final approval.
As a proposed constitutional amendment is debated in court, recent surveys of registered voters reveal approval ratings.
The Senate recently passed a bill that would enable veterans to discuss and be recommended medical cannabis by Veterans Affairs doctors.
The measure was approved to be on the ballot in August after a campaign led by citizens.